Moreover, because carnitine also offers antioxidant and anti-inflammatory effects, it has been shown to reduce markers of vascular injury in patients undergoing hemodialysis and in those with peripheral vascular disease (11, 12)
Despite a large volume of preclinical data suggesting a favourable safety profile and therapeutic potential, BPC-157 remains an investigational compound, not approved for human use by any global drug regulatory agency, and its use is prohibited in competitive sports
10.1038/s41386-019-0531-4 Summary Keywords addiction, dependence, reward, dopamine, gutbrain axis, appetite regulation Citation Jerlhag E (2023) The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
Its important to note that these dosing protocols were established within the context of clinical trials
Protection of peripheral nerve function post-injury
GLP-1 medications have long half-lives